Publication: A Founder Effect Led Early Sars-Cov-2 Transmission In Spain
| dc.contributor.author | Díez-Fuertes, Francisco | |
| dc.contributor.author | Iglesias-Caballero, Maria | |
| dc.contributor.author | García-Pérez, Javier | |
| dc.contributor.author | Monzon-Fernandez, Sara | |
| dc.contributor.author | Jimenez Sancho, Maria Pilar | |
| dc.contributor.author | Varona Fernandez, Sarai | |
| dc.contributor.author | Cuesta de la Plaza, Isabel | |
| dc.contributor.author | Zaballos, Ángel | |
| dc.contributor.author | Jimenez, Mercedes | |
| dc.contributor.author | Checa, Laura | |
| dc.contributor.author | Pozo Sanchez, Francisco | |
| dc.contributor.author | Perez-Olmeda, Mayte | |
| dc.contributor.author | Thomson, Michael M | |
| dc.contributor.author | Alcamí, José | |
| dc.contributor.author | Casas Flecha, Inmaculada | |
| dc.contributor.funder | Red de Investigación Cooperativa en Investigación en Sida (España) | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.date.accessioned | 2020-11-04T12:48:55Z | |
| dc.date.available | 2020-11-04T12:48:55Z | |
| dc.date.issued | 2021-01 | |
| dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole-genome analysis has identified five large clades worldwide which emerged in 2019(19A and 19B) and in 2020 (20A, 20B, and 20C). This study aimed to analyze the dif-fusion of SARS-CoV-2 in Spain using maximum-likelihood phylogenetic and Bayesianphylodynamic analyses. The most recent common ancestor (MRCA) of the SARS-CoV-2 pandemic was estimated to have emerged in Wuhan, China, around 24 No-vember 2019. Phylogenetic analyses of the first 12,511 SARS-CoV-2 whole-genomesequences obtained worldwide, including 290 from 11 different regions of Spain, re-vealed 62 independent introductions of the virus in the country. Most sequencesfrom Spain were distributed in clades characterized by a D614G substitution in the Sgene (20A, 20B, and 20C) and an L84S substitution in ORF8 (19B) with 163 and 118sequences, respectively, with the remaining sequences branching in 19A. A total of110 (38%) sequences from Spain grouped in four different monophyletic clusters ofclade 20A (20A-Sp1 and 20A-Sp2) and 19B clade (19B-Sp1 and 19B-Sp2) along withsequences from 29 countries worldwide. The MRCAs of clusters 19A-Sp1, 20A-Sp1,19A-Sp2, and 20A-Sp2 were estimated to have occurred in Spain around 21 and 29January and 6 and 17 February 2020, respectively. The prevalence of clade 19B inSpain (40%) was by far higher than in any other European country during the firstweeks of the epidemic, probably as a result of a founder effect. However, this vari-ant was replaced by G614-bearing viruses in April.In vitroassays showed an en-hanced infectivity of pseudotyped virions displaying the G614 substitution comparedwith those having D614, suggesting a fitness advantage of D614G. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work was partially supported by the Spanish AIDS Research Network (RIS), funded by Instituto de Salud Carlos III and co-funded by European Development Fund (ERDF) “A way to build Europe” (project RD16CIII/0002/0001) and by the COVID funding project “Coordinación de actividades de investigación en el CNM para realizar una respuesta integradora frente a la pandemia por el SARS-CoV-2 en España”from Instituto de Salud Carlos III (project COV20_00679, MPY 222-20). | es_ES |
| dc.identifier.citation | J Virol. 2021 Jan 13;95(3):e01583-20. | es_ES |
| dc.identifier.doi | 10.1128/JVI.01583-20 | es_ES |
| dc.identifier.e-issn | 1098-5514 | |
| dc.identifier.issn | 0022-538X | |
| dc.identifier.journal | Journal of virology | es_ES |
| dc.identifier.pubmedID | 33127745 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/11291 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Society for Microbiology (ASM) | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0002/0001 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/COV20_00679 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/MPY222-20 | es_ES |
| dc.relation.publisherversion | http://dx.doi.org/10.1128/JVI.01583-20 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.centro | ISCIII::Unidad de Investigación en Telemedicina y eSalud | |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | COVID-19 | |
| dc.subject | Europe | |
| dc.subject | SARS-CoV | |
| dc.subject | Spain | |
| dc.subject | Phylodynamics | |
| dc.title | A Founder Effect Led Early Sars-Cov-2 Transmission In Spain | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 05199c38-bb50-4a79-bb3b-96dce9769920 | |
| relation.isAuthorOfPublication | f055c52d-7163-4b68-8701-12a3b6533144 | |
| relation.isAuthorOfPublication | e4416b9d-e4ad-48e5-a0b6-e760b90bf5c5 | |
| relation.isAuthorOfPublication | 7cffc9dc-bb9e-4d48-a041-5fb6013b1b65 | |
| relation.isAuthorOfPublication | ef8f3af7-9fa4-45f5-b91b-dfdd7f22e593 | |
| relation.isAuthorOfPublication | 260126e8-85b9-4808-aa25-23cc4653d3bf | |
| relation.isAuthorOfPublication | 649d9dae-bb8e-46b3-82f3-e9b14d2a3670 | |
| relation.isAuthorOfPublication | 67cd15ad-351b-4b96-97ff-d7ef6d125415 | |
| relation.isAuthorOfPublication | 1cacaac4-2f79-4c26-8770-a36de8770a19 | |
| relation.isAuthorOfPublication | 5611ffc3-de88-4908-b20a-9a15a58c060a | |
| relation.isAuthorOfPublication | d01866d4-34ba-4cd6-b995-3c4199bf0c59 | |
| relation.isAuthorOfPublication | ad673934-9665-4352-b498-c694bf04ae3c | |
| relation.isAuthorOfPublication | 2fc55aca-54b0-411c-b170-c2149068a902 | |
| relation.isAuthorOfPublication | e2df6e55-f1d3-423b-a72f-fd9a69cf5915 | |
| relation.isAuthorOfPublication.latestForDiscovery | 05199c38-bb50-4a79-bb3b-96dce9769920 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | efa64f05-b985-4984-8f1e-5fc4ef21f502 | |
| relation.isFunderOfPublication.latestForDiscovery | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isPublisherOfPublication | 30cd8aef-e018-40d1-b05e-19af778995bd | |
| relation.isPublisherOfPublication.latestForDiscovery | 30cd8aef-e018-40d1-b05e-19af778995bd |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- FounderEffectLedEarlySARS-CoV-2_2021.pdf
- Size:
- 4.2 MB
- Format:
- Adobe Portable Document Format
- Description:


